NCT06115772
- Conditions
- Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
Explore clinical trials studying Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma trial results
Not yet recruiting
A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED)
NCT07418034
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +38 more
- Locations
-
Not specified
Active, not recruiting
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344
- Conditions
- Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +10 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- RWJBarnabas Health - Robert Wood Johnson University Hospital, New Brunswick New Brunswick, New Jersey, United States
- Rutgers Cancer Institute of New Jersey at University Hospital Newark, New Jersey, United States